Hypolipidemic 4, 5-dihydro-4-oxo-5, 5-disubstituted-2-furancarboxylic acids
I Jirkovsky, MN Cayen
Index: Jirkovski, Ivo; Cayen, Mitchell, N. Journal of Medicinal Chemistry, 1982 , vol. 25, # 10 p. 1154 - 1156
Full Text: HTML
Citation Number: 28
Abstract
A series of novel 4, 5-dihydro-4-oxo-5, 5-disubstituted-2-f~ ancarboxylic acids was synthesized and shown to possess potent hypotriglyceridemic activity in normal rats. In contrast to clofibrate, none of the present compounds altered liver weight at any dose. Being more potent than nicotonic acid and clofibrate, 4, 5-dihydro-5-methyl-4-0~ 0-5-phenyl-2- furancarboxylic acid (5b, AY-25,712) has been selected for clinical trials.
Related Articles:
[Ca', Nicola Della; Gabriele, Bartolo; Ruffolo, Giuseppe; Veltri, Lucia; Zanetta, Tito; Costa, Mirco Advanced Synthesis and Catalysis, 2011 , vol. 353, # 1 p. 133 - 146]
[Kise, Naoki; Agui, Syun; Morimoto, Shinji; Ueda, Nasuo Journal of Organic Chemistry, 2005 , vol. 70, # 23 p. 9407 - 9410]
Rhodium-catalyzed addition of arylstannanes to carbon–heteroatom double bond
[Oi, Shuichi; Moro, Mitsutoshi; Fukuhara, Hiroe; Kawanishi, Takanori; Inoue, Yoshio Tetrahedron, 2003 , vol. 59, # 24 p. 4351 - 4361]
Novel routes to N-amino-1H-pyrrolo [2, 3-b] pyridines from α-hydroxyarylalkyl ketones and hydrazines
[Chudinov; Gashev; Firgang; Semenov Russian Chemical Bulletin, 2007 , vol. 56, # 8 p. 1612 - 1616]
Oxidative and reductive carbodiazenylation of nonactivated olefins
[Adlington, Robert M.; Baldwin, Jack E.; Bottaro, Jeffrey C.; Perry, Matthew W. D. Journal of the Chemical Society, Chemical Communications, 1983 , # 18 p. 1040 - 1041]